These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16154163)

  • 21. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways.
    Hussain S; Wilson JB; Medhurst AL; Hejna J; Witt E; Ananth S; Davies A; Masson JY; Moses R; West SC; de Winter JP; Ashworth A; Jones NJ; Mathew CG
    Hum Mol Genet; 2004 Jun; 13(12):1241-8. PubMed ID: 15115758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
    Tacconi EM; Lai X; Folio C; Porru M; Zonderland G; Badie S; Michl J; Sechi I; Rogier M; Matía García V; Batra AS; Rueda OM; Bouwman P; Jonkers J; Ryan A; Reina-San-Martin B; Hui J; Tang N; Bruna A; Biroccio A; Tarsounas M
    EMBO Mol Med; 2017 Oct; 9(10):1398-1414. PubMed ID: 28729482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impairment of homologous recombination control in a Fanconi anemia-like Chinese hamster cell mutant.
    Larminat F; Germanier M; Papouli E; Defais M
    Biol Cell; 2004 Sep; 96(7):545-52. PubMed ID: 15380621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor.
    Rego MA; Harney JA; Mauro M; Shen M; Howlett NG
    Oncogene; 2012 Jan; 31(3):366-75. PubMed ID: 21685936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homozygous germ line mutation in exon 27 of murine Brca2 disrupts the Fancd2-Brca2 pathway in the homologous recombination-mediated DNA interstrand cross-links' repair but does not affect meiosis.
    Atanassov BS; Barrett JC; Davis BJ
    Genes Chromosomes Cancer; 2005 Dec; 44(4):429-37. PubMed ID: 16127665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein.
    Fei P; Yin J; Wang W
    Cell Cycle; 2005 Jan; 4(1):80-6. PubMed ID: 15611632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fanconi anemia: genes and function(s) revisited].
    Papadopoulo D; Moustacchi E
    Med Sci (Paris); 2005; 21(8-9):730-6. PubMed ID: 16115458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired removal of DNA interstrand cross-link in Nijmegen breakage syndrome and Fanconi anemia, but not in BRCA-defective group.
    Tsuchida K; Komatsu K
    Cancer Sci; 2008 Nov; 99(11):2238-43. PubMed ID: 18771529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the link between MORF4L1 and risk of breast cancer.
    Martrat G; Maxwell CM; Tominaga E; Porta-de-la-Riva M; Bonifaci N; Gómez-Baldó L; Bogliolo M; Lázaro C; Blanco I; Brunet J; Aguilar H; Fernández-Rodríguez J; Seal S; Renwick A; Rahman N; Kühl J; Neveling K; Schindler D; Ramírez MJ; Castellà M; Hernández G; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Davidson R; Ong KR; Cook J; Douglas F; Hodgson S; Brewer C; Morrison PJ; Porteous M; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Pasini B; Ottini L; Putignano AL; Savarese A; Bernard L; Radice P; Healey S; Spurdle A; Chen X; Beesley J; ; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Asperen CJ; Bodmer D; Ausems MG; van Os TA; Blok MJ; Meijers-Heijboer HE; Hogervorst FB; ; Goldgar DE; Buys S; John EM; Miron A; Southey M; Daly MB; ; ; Harbst K; Borg A; Rantala J; Barbany-Bustinza G; Ehrencrona H; Stenmark-Askmalm M; Kaufman B; Laitman Y; Milgrom R; Friedman E; Domchek SM; Nathanson KL; Rebbeck TR; Johannsson OT; Couch FJ; Wang X; Fredericksen Z; Cuadras D; Moreno V; Pientka FK; Depping R; Caldés T; Osorio A; Benítez J; Bueren J; Heikkinen T; Nevanlinna H; Hamann U; Torres D; Caligo MA; Godwin AK; Imyanitov EN; Janavicius R; ; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Verny-Pierre C; Castera L; de Pauw A; Bignon YJ; Uhrhammer N; Peyrat JP; Vennin P; Ferrer SF; Collonge-Rame MA; Mortemousque I; McGuffog L; Chenevix-Trench G; Pereira-Smith OM; Antoniou AC; Cerón J; Tominaga K; Surrallés J; Pujana MA
    Breast Cancer Res; 2011 Apr; 13(2):R40. PubMed ID: 21466675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathogenesis of fanconi anemia.
    Taniguchi T; Dandrea AD
    Int J Hematol; 2002 Feb; 75(2):123-8. PubMed ID: 11939257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fanconi anemia: causes and consequences of genetic instability.
    Kalb R; Neveling K; Nanda I; Schindler D; Hoehn H
    Genome Dyn; 2006; 1():218-242. PubMed ID: 18724063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells.
    Bruun D; Folias A; Akkari Y; Cox Y; Olson S; Moses R
    DNA Repair (Amst); 2003 Sep; 2(9):1007-13. PubMed ID: 12967657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant.
    Tebbs RS; Hinz JM; Yamada NA; Wilson JB; Salazar EP; Thomas CB; Jones IM; Jones NJ; Thompson LH
    DNA Repair (Amst); 2005 Jan; 4(1):11-22. PubMed ID: 15533833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C. elegans: a model of Fanconi anemia and ICL repair.
    Youds JL; Barber LJ; Boulton SJ
    Mutat Res; 2009 Jul; 668(1-2):103-16. PubMed ID: 19059419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.
    Vilcheck SK; Ceryak S; O'Brien TJ; Patierno SR
    Mutat Res; 2006 Nov; 610(1-2):21-30. PubMed ID: 16893675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional interaction between the Fanconi Anemia D2 protein and proliferating cell nuclear antigen (PCNA) via a conserved putative PCNA interaction motif.
    Howlett NG; Harney JA; Rego MA; Kolling FW; Glover TW
    J Biol Chem; 2009 Oct; 284(42):28935-42. PubMed ID: 19704162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.
    Chen X; Bosques L; Sung P; Kupfer GM
    Oncogene; 2016 Jan; 35(1):22-34. PubMed ID: 25893307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex.
    Doss CG; Nagasundaram N
    Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FANCD1/BRCA2 plays predominant role in the repair of DNA damage induced by ACNU or TMZ.
    Kondo N; Takahashi A; Mori E; Noda T; Zdzienicka MZ; Thompson LH; Helleday T; Suzuki M; Kinashi Y; Masunaga S; Ono K; Hasegawa M; Ohnishi T
    PLoS One; 2011 May; 6(5):e19659. PubMed ID: 21573016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic exploitation of tumor cell defects in homologous recombination.
    Powell SN; Kachnic LA
    Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.